PARP Inhibitor Offers Improved Quality of Life in Advanced Breast Cancer

Treatment with talazoparib improved quality of life vs physician ’s choice of chemotherapy in patients with HER2-negative advanced breast cancer.

Source: CancerNetwork - August 29, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news